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Abstract
Background: The availability and effectiveness of decision aids (DAs) on early abortion
methods remain unknown, despite their potential for supporting women’s decision
making.
Objective: To describe the availability, impact and quality of DAs on surgical and medical early abortion methods for women seeking induced abortion.
Search strategy: For the systematic review, we searched MEDLINE, Cochrane Library,
CINAHL, EMBASE and PsycINFO. For the environmental scan, we searched Google
and App Stores and consulted key informants.
Inclusion criteria: For the systematic review, we included studies evaluating an early
abortion method DA (any format and language) vs a comparison group on women’s
decision making. DAs must have met the Stacey et al (2014). Cochrane review definition of DAs. For the environmental scan, we included English DAs developed for the
US context.
Data extraction and synthesis: We extracted study and DA characteristics, assessed
study quality using the Effective Practice and Organization of Care risk of bias tool and
assessed DA quality using International Patient Decision Aid Standards (IPDAS).
Results: The systematic review identified one study, which found that the DA group
had higher knowledge and felt more informed. The evaluated DA met few IPDAS criteria. In contrast, the environmental scan identified 49 DAs created by non-specialists.
On average, these met 28% of IPDAS criteria for Content, 22% for Development and
0% for Effectiveness.
Conclusions: Research evaluating DAs on early abortion methods is lacking, and although many tools are accessible, they demonstrate suboptimal quality. Efforts to revise existing or develop new DAs, support patients to identify high-quality DAs and
facilitate non-specialist developers’ adoption of best practices for DA development
are needed.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2017 The Authors Health Expectations Published by John Wiley & Sons Ltd
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1 | INTRODUCTION

evaluated using non-randomized study designs or developed and evaluated but not published in the scientific literature is unknown. What

As we have described previously,1 women in the United States value re2-4

5

also remains unclear is the availability and quality of decision aids that

and support when making decisions about

have not undergone evaluation, including those developed by entities

early abortion.6-9 The two recommended methods, surgical and medical

without specialist expertise in decision aid design (eg abortion clinics).

abortion, are both highly effective, safe and acceptable, yet differ across

Such decision aids may be more easily accessed by the general public

several aspects (eg duration, bleeding and cramping profile, where the

and thus more likely to be the first-line source of information.

ceiving quality information

10

According to a re-

The two objectives of this study were (i) to conduct a systematic

cent national survey of abortion providers,11 both methods are avail-

review to identify, appraise and evaluate the impact of early abortion

able in a majority of abortion facilities, and among those facilities that

method decision aids described in the scientific literature, and (ii) to

offer only the medical option, most are located in areas also served by

conduct an environmental scan of the grey literature to identify and

abortion takes place, follow-up visit requirements).

11

those that offer surgical abortion.

Recent changes to the US Food and

Drug Administration regulations for mifepristone-misoprostol medical

appraise other early abortion method decision aids developed in the
United States.

abortion are also anticipated to expand access to women.12 Given the
potential availability of both methods, and that they are similarly effective yet encompass very different processes, women’s preferences and

2 | METHODS

circumstances are paramount to their method choice.
Decision aids are tools designed to support patients to compare
medically appropriate options and make informed decisions based on
their preferences and quality evidence.

13

and summarized below.

They enable standardized,

patient-centred and balanced information provision and have been
shown to improve patients’ knowledge, participation in decision
making and the alignment between their choices and their values in
13

Study methods are described in detail in a published study protocol1

2.1 | Systematic review (Part I)
We registered the systematic review protocol on 12 February 2015

Decision aids are particularly relevant

with the International Prospective Register of Systematic Reviews

for the early abortion context given the prevalence of biased infor-

(CRD42015016717), and this reporting adheres to the PRISMA

mation about abortion,14 relatively poor knowledge about the safety

methodology.24

a range of clinical settings.

and consequences of abortion among the general public15,16 and the
diminishing access to qualified abortion providers17 who often serve
as an important source of trusted information.16 Moreover, because

2.1.1 | Inclusion and exclusion criteria

primary care providers sometimes have insufficient knowledge18 and

We included studies if they were randomized controlled trials or

training19 in early abortion methods, and counselling is not always

non-randomized, cohort, case-control, before-and-after, interrupted

integrating a consistent,

time series or repeated-
measures studies.25 They must have

high-quality decision aid may help health professionals across dis-

included women eligible for and facing a decision between medical

ciplines to better support women’s decision making process. Even

and surgical abortion (as defined by trialists), and collected patient-

in areas where there may not be ready access to both methods, a

or observer-reported data on the impact of an early abortion method

decision aid may enable women to develop accurate expectations

decision aid on women’s decision making processes or outcomes.

about the method that will be used and may also empower women

Our primary outcome was decision quality, defined as the extent

as consumer advocates. Despite the potential utility of a decision aid

to which a patient’s decision is informed and based on personal

on early abortion methods, we lack knowledge on the availability,

values.26-28

well received from abortion providers,

20

quality and impact of existing decision aids on this topic.

The decision aid must have met the definition adopted in the

The most recent Cochrane review of decision aids13 and two other

Cochrane review of decision aids available at the time the study was

systematic reviews21,22 identified a single study evaluating an early abor-

designed (ie “interventions designed to help people make specific and

tion method decision aid,23 which is no longer available to the public.

deliberative choices among options (including the status quo), by making

However, none of these reviews assessed the quality of identified deci-

the decision explicit and by providing (at the minimum) (i) information on

sion aids. Additionally, because these reviews included only randomized

the options and outcomes relevant to a person’s health status, and (ii)

controlled trials, whether other decision aids have been developed and

implicit methods to clarify values” (Stacey et al, p. 829)), compared
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medical and surgical early abortion methods,* been publicly available (ie

outcomes for the identified study. Abstracted data were compared

free) and been developed after 2000, when medical abortion became

and disagreements resolved by discussion.

legal in the United States.30 The decision aid could have been designed
for use at any time, in any format (eg electronic documents, static websites, interactive websites, videos, DVDs, pamphlets, booklets, smartphone mobile applications (“apps”)) and in any language.
After finalization of the study protocol,1 we elected also to exclude studies of women whose gestational age was unclear and studies evaluating decision coaching not accompanied by a physical tool.31

2.1.5 | Study and evidence quality appraisal
Both reviewers independently assessed the methodological quality using the Cochrane Effective Practice and Organization of Care
Group’s (EPOC) risk of bias criteria.34

2.1.6 | Decision aid quality appraisal

2.1.2 | Search strategy

The quality of the decision aid evaluated in the included study was as-

We searched MEDLINE/PubMed, The Cochrane Library, CINAHL,

of the International Patient Decision Aid Standards (IPDAS) checklist.35

EMBASE and PsycINFO using, where appropriate, medical subject heading (MeSH) terms: “abortion, induced,” “patient education,” “choice behavior,” “decision making” and “decision support techniques” and/or key
words with Boolean operators. We did not apply any language limits but,
reflecting decision aid inclusion criteria, we searched only for studies
published since January 2000, as described above. We also searched the
trial registry ClinicalTrials.gov, manually searched the reference list of the
included article (see Results) and considered for inclusion any decision aid
identified from the environmental scan that had been evaluated and published in a peer-reviewed outlet. We also reviewed any articles identified
in Google Scholar as having cited the included article. All searches were
conducted in February 2015 (search results included in Appendix S2).

sessed by the primary and secondary reviewers using the 2005 version
This checklist includes items in the Content domain (ie the information,
probabilities, values clarification and guidance in deliberation specific to
the health condition), Development domain (ie the design and development process) and Effectiveness domain (ie outcomes related to a high-
quality decision).35 Because the included study did not comprise decision
aids on a diagnostic test, there were 59 potentially relevant items, including supplementary items for Internet-based tools (6 items) and tools that
included patient stories (3 items). On the quality appraisal form developed for this study, minor clarifications or examples were added to some
checklist items to improve clarity and thus consistency in appraisal across
reviewers (form available in Appendix S1). Items that could not be confidently assessed with the information available were coded as not having
met the criteria. Items that were not applicable were coded as such.†

2.1.3 | Screening process
The screening and full review process of Internet pages and apps is
1

described in full in the protocol. We had planned to screen both titles
and abstracts of all articles after duplicate entries were removed,32
but ultimately opted to screen only titles unless further clarification
from the abstract was needed. This screening approach has been
shown to be as precise and more efficient than screening both titles

We used the Flesch-Kincaid test analytics in Microsoft Word to
assess the readability and reading ease (scale 0-100, higher is easier to
read) of text-based decision aids.36,37 We chose a readability level of
8th grade or below to indicate limited reading skills IPDAS (Item 42)
and to correspond with the mean reading level in the US population.38

2.1.7 | Analysis

and abstracts.33 The primary reviewer (KD) classified each article as

We had planned to perform a meta-analysis of study results, but only

“potentially eligible” or “ineligible” for inclusion and, for articles classi-

one eligible study was identified.

fied as “ineligible,” recorded the most salient reason. We had planned
that the secondary reviewer (RT) would independently screen random

2.2 | Environmental scan (Part II)

samples of 10% of the titles and/or abstracts in each classification (ie
“potentially eligible” and “ineligible”). However, because the primary
reviewer only identified 12 “potentially eligible” studies (see Results),
the second reviewer independently screened all of these studies (in
addition to the 10% of “ineligibles”). The reviewers’ classifications
matched exactly. The same process was used for full-text review.

2.1.4 | Data extraction
The primary and secondary reviewers used a customized form to independently extract data on the study design, participant characteristics,
decision aid characteristics (eg format, mode of administration) and
*

Decision aids that included other pregnancy options (eg adoption and/or continuing the
pregnancy) were included so long as they also compared medical and surgical early abortion
methods.

2.2.1 | Inclusion and exclusion criteria
For the environmental scan, we adopted all intervention inclusion and
exclusion criteria used in the systematic review and imposed two further criteria, excluding decision aids not written in English and those
not created by a source in the United States, for women living in the
United States.

2.2.2 | Search strategy
We conducted four Google searches using the following search
strings: (i) abortion options, (ii) abortion decision aid, (iii) medical or
†
There were two exceptions for Internet-based decision aids: those that comprised only one
tab and did not provide external links were coded as having met Items 44 and 48,
respectively.
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Identification

Articles identified through database
searching (n = 3294)
• PubMed – 1904
CINAHL – 292
Cochrane Library – 112
• EMBASE – 574
• PsychINFO – 394
• ClinicalTrials.gov – 18

Additional articles identified through
other sources (n = 45)
• References of included study – 25
• Articles citing included study – 20

Eligibility

Screening

Articles after duplicates removed
(n = 2930 )

Excluded (n = 2918 )
Articles screened
(n = 2930)

Full-text article assessed
(n = 12)

•
•
•
•

Date – 1271
Design – 1096
Intervention – 461
Population – 90

Excluded (n = 11)
• Design – 5
• Intervention – 4
• Population – 2

F I G U R E 1 Systematic review PRISMA
flow diagram

Included

Studies included
(n = 1)

surgical abortion, and (iv) pregnancy termination options. We searched
the Apple App Store and Google Play39 using the key word abor-

2.2.4 | Data extraction

tion. We also solicited information about decision aids via the

The primary reviewer used a customized form to extract data from all

National Abortion Federation and Abortion Care Network list-

eligible decision aids (eg format, characteristics and source).

servs and Twitter, emailed key informants who work in abortion
care and/or research (ie The American Congress of Obstetricians
and Gynecologists, Planned Parenthood Federation of America,

2.2.5 | Decision aid quality appraisal

Reproductive Health Access Project), and reviewed the Ottawa

The primary reviewer appraised the quality of all included decisions

Hospital Research Institute’s Decision Aid Library Inventory.40

using the IPDAS checklist and the Flesch-Kincaid tests. The second-

Additionally, the decision aid identified during the systematic review

ary and tertiary (GE) reviewers independently appraised the quality

was considered for the environmental scan. All searches were con-

of random samples of 10% of the eligible decision aids. Inter-rater

ducted in February 2015.

reliability for decision aid quality appraisals was calculated to be
κ = 0.74 and κ = 0.85, and again exceeded our minimum requirement.

2.2.3 | Screening process
The screening and full review process of Internet pages and apps is
described in full in the protocol.1 We had planned to classify tools as
“eligible” or “ineligible” for inclusion, but elected to add “unclear” as a

3 | RESULTS
3.1 | Systematic review

third classification due to unforeseen challenges in categorizing some

Altogether, 2930 unique articles were identified through database

of the resultant tools. We contacted two study authors for clarifying

searches and other search methods. Of those articles classified as

information about the study population, outcomes and intervention.

“potentially eligible” for inclusion, only one described a study that

The inter-rater reliability of eligible and ineligible classifications be-

met all eligibility criteria (see Figure 1). This study was the randomized

tween the primary and secondary was calculated to be κ = 0.74, and

controlled trial identified in prior systematic reviews.13,21,22 It was

thus exceeded our minimum requirement (0.7). For those classified

conducted in 2002 in the United Kingdom and randomized women

as “unclear,” the primary and secondary reviewers came to a decision

to receive either a three-page paper decision aid about early abortion

about eligibility together.

methods (n = 163) or a control leaflet about contraception (n = 165)
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T A B L E 1 Effective Practice and Organization of Care risk of bias
assessment
Criteria

Unclear

Low

Sequence generation

✓

Allocation concealment

✓

Similar baseline outcome
measurements

abortion than women randomized to receive the control leaflet. No
differences were found between groups in scores on the Uncertain or
Effectiveness subscales of the Decisional Conflict Scale, level of anxi-

High

ety, attitudes towards surgical abortion or chosen abortion method.
Although there were mixed findings about the effect of group on risk
perception scores about each method, generally, women in the deci-

✓

Similar baseline characteristics

sion aid group had lower scores. Other study outcomes are described
in the Cochrane Collaboration review of decision aids13 and the two

✓

Blinding

other systematic reviews mentioned previously.21,22

✓

Incomplete outcome data

✓

Contamination

3.1.2 | Decision aid quality appraisal

✓

Selective outcome reporting

✓

Other sources of potential bias

The decision aid met 5 of 23 IPDAS criteria for the Content domain
of the IPDAS checklist, 11 of 20 for Development and 1 of 7 for

✓

Effectiveness. The Flesch-Kincaid readability was calculated to be US
in the waiting room before an abortion counselling consultation. We

grade level 6.9 and 62.9 reading ease.

contacted the corresponding author to clarify the study outcomes and
to inquire about related publications (eg study protocols, companion

3.1.3 | Study and evidence quality appraisal

studies), none of which were identified.

Using the EPOC risk of bias criteria, the study was classified as hav-

3.1.1 | Decision aid impact

ing low risk of bias in five of nine domains (see Table 1). The study

The included study found that women randomized to receive the de-

tion (because randomization was at the patient level) and selective

cision aid had higher levels of knowledge about both methods, had

outcome reporting (because they used the entire Decisional Conflict

more favourable scores on the Informed subscale of the Decisional

Scale but only reported select subscales). The risk of bias was unclear

Conflict Scale and expressed more positive attitudes towards medical

for similar baseline characteristics (because no baseline outcome

was classified as having high risk of bias in two domains: contamina-

Identification

Additional tools identified through
other sources (n = 19)

Tools identified through internet and
app store searching
(n = 500)

•
•
•
•

Internet – 10
Apps – 1
Key informants – 7
Systematic review – 1

Screening and eligibility

Tools after duplicates removed
(n = 434)

Tools screened and
assessed for eligibility
(n = 434)

Tools excluded (n = 385)
• Not a decision aid (n = 341)
• Not about early abortion (n =
29)
• International (n = 5)
• Not English (n = 3)
• Unable to obtain (n = 3)
• Not working (n = 3)
• Not free (n = 1)

Included

Decision aids included in
IPDAS rating and content
analysis
(n = 49)

F I G U R E 2 Environmental scan PRISMA
flow diagram

|
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T A B L E 2 Average International Patient
Decision Aid Standards scores for different
types of decision aids

Decision aid type

Content

Development
a

321

Effectiveness

Website with
narratives (n = 4)

6.5/23 = 28%
(range: 6-9)

6.5/27 = 24%
(range: 6-7)

0/7 = 0%

Website without
narratives (n = 38)

6.6/23 = 29%
(range: 3-12)

5.6/24b = 23%
(range: 2-11)

0/7 = 0%

PDF (n = 2)

6/23 = 26%
(range: 6)

4.5/20c = 23%
(range: 4-5)

0/7 = 0%

Smartphone app (n = 4)

4/23 = 17%
(range: 4)

4/23d = 17%
(range: 4)

0/7 = 0%

Audiovisual (n = 1)

7/23 = 30%

2/18e = 11%

0/7 = 0%

The denominator varied based on the number of applicable IPDAS items. Items that were not applicable are indicated as such: a46, 47; b46, 47, 50, 51, 52; c44, 45, 46, 47, 48, 49, 50, 51, 52; d46, 47, 48, 50,
51, 52; e41, 42, 44, 45, 46, 47, 48, 49, 50, 51, 52.

measurements were obtained) and for blinding (because no primary
outcome was specified). No other sources of potential bias were
identified.

3.2.2 | Decision aid quality
On average, the decision aids met the criteria for 28% (n = 6) of the

Due to the identification of only one study, we were not able to

23 items for Content (range: 3-12) and 0% (n = 0) of the 7 items for

use the Grading of Recommendations Assessment, Development

Effectiveness domains (see Figure 1). Due to the nature of the included

and Evaluation (GRADE) criteria to rate the quality of evidence as

decision aids, the number of applicable items in the Development do-

planned.41

main varied from 18 to 27, with an average of 22% (n = 5) of items met
(range: 2-11). Table 2 provides an overview of the average scores (and

3.2 | Environmental scan

ranges) for different types of decision aids. A table of scores by each
decision aid is available upon request.

Altogether, 434 unique tools were identified through Internet and App

The decision aids met more IPDAS items in the Content and

Store searches and other sources. Of these, 49 met eligibility criteria

Development domains than in the Effectiveness domain, as described

(see Figure 2). Three sources referenced a decision aid, but we were un-

in Table 3 with clarifying comments.

able to obtain them despite attempts to contact the authors. The vast
majority of the excluded tools did not meet the definition of a decision
aid (ie they failed to make the decision explicit and/or to include implicit

4 | DISCUSSION

methods to clarify values (n = 341)).29 The decision aid identified in the
systematic review did not meet eligibility criteria for the environmental

This systematic review and environmental scan found that very lim-

scan because it was not created for women in the United States.

ited research has examined the impact of early abortion method decision aids, and although many are highly accessible, their quality scores

3.2.1 | Decision aid characteristics

are suboptimal. The low scores can be attributed, in part, to many
decision aids describing method features inconsistently and with un-

Most of the included decision aids (n = 42) were non-interactive

equal detail, and presenting information in a disorganized fashion,

multipage websites that averaged 14.6 pages in length (range 2-208

potentially undermining perceptions of balance among users42 and

pages). The remaining decision aids comprised 4 Apple Smartphone

impeding values-consistent decision making. This is likely exacerbated

apps, 2 PDFs and 1 video. All decision aids appeared to be cre-

among women with low literacy given that the majority of decision

ated by entities without specialist expertise in decision aid devel-

aids did not meet readability standards.38

opment, including 32 by abortion services, seven by reproductive

The poor quality of existing early abortion methods decision aids

health-related organizations, four by consumer health information

not only represents a lost opportunity for supporting women’s deci-

organizations, four by pregnancy clinics that do not provide abor-

sion making, but may also affect their care experiences. For exam-

tion procedures or referral, one by a clinician and one by a patient

ple, most tools did not describe the emotional and/or social effects

advocate. All decision aids compared at least one method of early

of one or both methods transparently, so women who are concerned

surgical and medical abortion, with the majority describing some

with these attributes may develop preferences for a less appropriate

type of early surgical abortion to medical abortion with mifepristone

method. Because some women report choosing their method be-

and misoprostol. Three decision aids also compared manual vacuum

fore approaching the health system,9 health professionals who offer

aspiration to electrical vacuum aspiration. Thirteen decision aids

abortion services, counselling and/or referral may need to be pre-

also described methotrexate and one, tamoxifen, as alternatives to

pared to spend more time addressing such misperceptions and offer-

mifepristone.

ing evidence-based counselling, particularly among women with low
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Number of decision aids that met each International Patient Decision Aid Standards (IPDAS) criteria

IPDAS criteria

n

Comments

Describe the health condition

32/49

Sometimes failed to explain that abortion is performed to end a pregnancy.

List the options

49/49

List the option of doing nothing

18/49

Majority did not list the alternative options (ie adoption or continuing the
pregnancy).

6/49

Few included information about the process of continuing the pregnancy.

Content

Describe the natural course without options
Describe procedures

38/49

Describe positive features

35/49

Describe negative features of options

46/49

Include chances that positive and negative outcomes
may happen

0/49

Descriptions typically comprised qualitative information (eg “you may
experience heavy bleeding”) instead of probabilities on the likelihood of
experiencing certain outcome.

Use event rates specifying the population and time
period

0/49

Quantitative data were used selectively (eg success or failure rates were
commonly provided, but not rates for other positive and negative
outcomes).

Compare outcome probabilities using the same
denominator, time period, scale

0/49

Describe uncertainty around probabilities

18/49

Descriptions were usually qualitative (eg “you cannot predict what exactly
will happen to you” or “the [side effect] may happen”).

Use visual diagrams

1/49

Use multiple methods to view probabilities (words,
numbers, diagrams)

0/49

Allow the patient to select a way of viewing
probabilities

0/49

Allow the patient to view probabilities based on their
own situation

0/49

Place probabilities in context of other events

0/49

The risk of having an abortion was often described in relative terms and the
“risk” was not defined (eg “far less than the risk of carrying a pregnancy and
giving birth”)

Use both positive and negative frames

0/49

Frequently gave success or failure rates, but rarely provided both.

Describe the procedures and outcomes to help patients
imagine what it is like to experience their physical,
emotional and social effects

17/49

All included some description of the methods’ physical effects, but often
omitted the emotional and/or social effects of one or both methods.

Ask patients to consider what positive and negative
features matter most

29/49

Majority provided implicit values clarification methods (eg table, list of pros
and cons, list of reasons why women choose one vs the other) and omitted
explicit values clarification methods.

Suggest ways for patients to share what matters most
with others

2/49

Provide steps to make a decision

2/49

Suggest ways to talk about the decision with a health
professional

3/49

Include tools to discuss options with others

7/49

Infrequently provided question lists, which sometimes had limitations (eg
only included questions for surgical abortion or listed generic and not
applicable questions, such as “will this surgery be laparoscopy or open
surgery?”). Women were rarely encouraged to write down their own
questions.

Development
Able to compare positive and negative features of
options

28/49

The type, amount and organization of information given for each method
was often inconsistent. Information was commonly presented in blocks of
text under subcategories (eg side-effects) or as answers to frequently asked
questions, yet the content was often presented in different orders and with
varying levels of detail. When information was presented in a table (n = 18),
there was more consistency and equitable detail.
(Continues)
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TABLE 3

323

(Continued)

IPDAS criteria

n

Comments

Show negative and positive features with equal detail

24/49

The majority described the positive or negative features inconsistently, with
the negative features emphasized more often.

Include developers’ credentials/qualifications

9/49

Find out what users need to discuss options

0/49

Has peer review by patient/professional experts not
involved in development and field testing

0/49

Is field tested with users

0/49

The field tests with users show the decision aid is
acceptable

0/49

The field tests with users show the decision aid is
balanced for undecided patients

0/49

The field tests with users show the decision aid is
understood by those with limited reading skills

0/49

Provide reference to evidence used

6/49

Report steps to find, appraise, summarize evidence

0/49

Report date of last update
Report how often patient decision aid is updated

49/49
2/49

Describe the quality of the scientific evidence

0/49

Use evidence from studies of patients similar to those of
target audience

6/49

Report source of funding to develop and distribute the
decision aid

0/49

Report where authors or their affiliations stand to gain
or lose by choices patients make after using the
decision aid

0/49

Is written at a level that can be understood by the
majority of patients in the target group.

9/48

Is written at a grade 8 equivalent level or less according
to readability score

11/48

The average US grade level required to understand the material was 9.6
(range: 5.1-12) and the reading ease was 51.3 (range: 31.7-65.1).

Provide ways to help patients understand information
other than reading

33/49

The majority indicated that in-person counselling would be available.

Provide a step-by-step way to move through the web
pages

34/46

Allow patients to search for key words

12/46

Provide feedback on PHI that is entered into the patient
decision aid

0/0

Provide security for PHI entered into the decision aid

0/0

Make it easy for patients to return to the decision aid
after linking to other web pages

20/46

Permit printing as a single document

14/46

Use stories that represent a range of positive and
negative experiences

0/4

Report if there was a financial or other reason why
patients decide to share their story

0/4

State in an accessible document that the patient gave
informed consent to use their stories

0/4

Effectiveness
(Continues)
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(Continued)

IPDAS criteria

n

Comments

Recognize a decision needs to be made

0/49

Know options and their features

0/49

Understand that values affect decision

0/49

Be clear about option features that matter most

0/49

Discuss values with their practitioner

0/49

Become involved in preferred ways

0/49

Improve the match between the chosen option and
the features that matter most to the informed
patient

0/49

No evidence of evaluations was found.

literacy. This exchange may be particularly challenging in states that

contact decision aid developers to solicit further information about

mandate the delivery of information during abortion counselling that

development and evaluation processes, we may have underestimated

14,43

which

the quality of some decision aids on these IPDAS domains. Third, be-

some providers believe interferes with patient-provider trust and rap-

is both inaccurate and not informed by patient preferences,

cause it was the most comprehensive, we adopted the 64-item IPDAS

port.44 This exchange may also lead women to opt for the alternative

checklist for decision aid appraisal. To our knowledge, this checklist

method, potentially inconveniencing both the patient and clinic with

has not previously been used to appraise decision aids developed by

additional costs and logistical burdens that could have been avoided.

non-specialists and thus may be less well suited to accurately capture

By partnering with women and health professionals (ie end-users) to

the strengths and weaknesses of these tools. Lastly, by excluding stud-

understand their decision support priorities (eg optimal information

ies evaluating decision coaching without an accompanying decision

content, presentation and delivery), there is significant opportunity to

aid, we were unable to investigate the impact of different approaches

develop a more quality, relevant and sustainable

45-47

early abortion

method decision aid to promote patient-centred and efficient abortion
care.48

to decision support in this context.
These limitations are, however, balanced by several strengths.
First, we adopted an environmental scan methodology in addition to

This study has implications for the current debate on decision aid
49-51

the more traditional systematic review, which proved essential for re-

Our finding that, for this topic, decision aids pro-

liably understanding the current decision aid landscape in this area.

duced by entities without specialist expertise in decision aid design

We highly recommend that an environmental scan methodology be

predominate suggests that a certification approach that encompasses

adopted more widely in attempts to understand the resources or in-

only tools produced by specialist developers may miss most of the

terventions available to patients. Second, unlike a prior study that ad-

decision aids accessible to patients via the Internet or other chan-

opted an environmental scan,54 our methodology purposefully sought

nels. Although reviewing all accessible decision aids for certification

to identify tools that met the Cochrane definition of a decision aid,

is clearly unrealistic, we recommend attention be paid to strategies

whether developed by specialists or non-specialists. This prior study

for supporting patients to seek and recognize high-quality, certified

started with a baseline understanding of a decision aid and included

decision aids, and to understand the reasons for their superiority.

only those tools that had a certain focus (ie prenatal testing), which

Furthermore, our finding that most of the decision aids met limited

likely missed some of the decision aids created by non-specialists.

criteria on the 64-item IPDAS checklist suggests discordance between

Third, we used reliable screening and appraisal tools for the system-

the priorities of subject matter experts and non-specialist developers.

atic review and environmental scan, evidenced by the adequate/high

A certification process that adopts more parsimonious quality criteria,

agreement between independent reviewers.

certification.

such as the IPDAS minimum standards,52 may be the most suitable for
ensuring decision aids achieve acceptable quality but can still be tailored to reflect real-world needs.53 Simultaneously, efforts to facilitate
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non-specialist developers’ understanding of best practice standards
for decision development and evaluation, and to encourage submis-

This systematic review and environmental scan demonstrate that

sion of decision aids for review and certification are warranted.

research examining the impact of decision aids on early abortion

There are four main limitations of this study. First, because our

methods is lacking, despite their potential to address key barriers to

focus was on understanding the early abortion method decision aid

women’s decision making process. Although many decision aids on

landscape for women in the United States, our systematic review

this topic have been developed and made accessible in the United

excluded studies published before 2000 and thus may have omit-

States, they are mostly poor quality and possibly undermining,

ted studies conducted earlier in countries with a longer history of

rather than enhancing, quality decision making by women. Adapting

performing medical abortion. Second, because we elected not to

an existing decision aid or developing a new decision aid on early

DONNELLY et al.

abortion methods in partnership with end-users and consistent with
best practice decision aid standards is recommended.
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